| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |